Tositumomab and iodine -131 tositumomab (Bexxar) is a new radioimmunotherapy in development for the treatment of low-grade or transformed, low-grade non-Hodgkin’s lymphoma (NHL).
N. K. Valente
Advertisement
Articles by N. K. Valente
Advertisement
Latest Updated Articles
- Iodine-131 Tositumomab For Patients With Small Lymphocytic Lymphoma (SLL): Overall Clinical Trial Experience
Published: March 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma
3
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
4
Highlighting the Importance of Advanced Diagnostics for GI Tumor Expression
5
